[1] WATSON R R,PREEDY V R.Probiotics,prebiotics,and synbiotics[M].Pittsburgh:Academic Press,2016:75-85.
[2] XUE L,HE J T,GAO N,et al.Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia[J].Scientific Reports,2017,7:45176.
[3] VALERIANO V D V,BALOLONG M P,KANG D K.Probiotic roles of
Lactobacillus sp. in swine:insights from gut microbiota[J].Journal of Applied Microbiology,2017,122(3):554-567.
[4] GAO J S,WU H W,LIU J F.Importance of gut microbiota in health and diseases of new born infants[J].Experimental and Therapeutic Medicine,2016,12(1):28-32.
[5] TURNER J R.Intestinal mucosal barrier function in health and disease[J].Nature Reviews Immunology,2009,9(11):799-809.
[6] SHIN K,FOGG V C,MARGOLIS B.Tight junctions and cell polarity[J].Annual Review of Cell and Developmental Biology,2006,22:207-235.
[7] 谭悦,郑长清.紧密连接蛋白occludin、
ZO-1在溃疡性结肠炎中的表达及其临床意义[J].现代药物与临床,2018,33(7):1803-1808.
[8] 王婷婷,王雪芹,霍贵成.乳酸杆菌对感染大肠杆菌O157:H7小鼠肠道黏膜免疫的影响[J].微生物学通报,2014,41(10):2082-2089.
[9] 王旭霞,赵曙光,刘震雄,等.双歧杆菌对溃疡性结肠炎大鼠肠黏膜屏障功能及细胞因子的影响[J].山西医科大学学报,2011,42(8):621-623,694.
[10] 张文远,姜伟炜.肠道微生态对三硝基苯磺酸诱导大鼠结肠炎肠黏膜上皮细胞紧密连接蛋白occludin保护作用的研究[J].临床消化病杂志,2010,22(1):21-24.
[11] FURUSE M,HIRASE T,ITOH M,et al.Occludin:a novel integral membrane protein localizing at tight junctions[J].The Journal of Cell Biology,1993,123(6):1777-1788.
[12] ANDO-AKATSUKA Y,SAITOU M,HIRASE T,et al.Interspecies diversity of the occludin sequence:cDNA cloning of human,mouse,dog,and rat-kangaroo homologues[J].The Journal of Cell Biology,1996,133(1):43-47.
[13] SAITOU M,ANDO-AKATSUKA Y,ITOH M,et al.Mammalian occludin in epithelial cells:its expression and subcellular distribution[J].European Journal of Cell Biology,1997,73(3):222-231.
[14] CUMMINS P M.Occludin:one protein,many forms[J].Molecular and Cellular Biology,2012,32(2):242-250.
[15] VAN ITALLIE C M,ANDERSON J M.Occludin confers adhesiveness when expressed in fibroblasts[J].Journal of Cell Biology,1997,110(9):1113-1121.
[16] MEDINA R,RAHNER C,MITIC L L,et al.Occludin localization at the tight junction requires the second extracellular loop[J].The Journal of Membrane Biology,2000,178(3):235-247.
[17] MANDELL K J,PARKOS C A.The JAM family of proteins[J].Advanced Drug Delivery Reviews,2005,57(6):857-867.
[18] BOLINGER M T.Phosphorylation of the tight junction protein occludin regulates epithelial monolayer proliferation and maturation[D].Ph.D.Thesis.Ann Arbor:University of Michigan,2016.
[19] TOKUNAGA Y,KOJIMA T,OSANAI M,et al.A novel monoclonal antibody against the second extracellular loop of occludin disrupts epithelial cell polarity[J].Journal of Histochemistry & Cytochemistry,2007,55(7):735-744.
[20] ODENWALD M A,CHOI W,BUCKLEY A,et al.ZO-1 interactions with F-actin and occludin direct epithelial polarization and single lumen specification in 3D culture[J].Journal of Cell Science,2017,130(1):243-259.
[21] BALDA M S,FLORES-MALDONADO C,CEREIJIDO M,et al.Multiple domains of occludin are involved in the regulation of paracellular permeability[J].Journal of Cellular Biochemistry,2000,78(1):85-96.
[22] MIR H,MEENA A S,CHAUDHRY K K,et al.Occludin deficiency promotes ethanol-induced disruption of colonic epithelial junctions,gut barrier dysfunction and liver damage in mice[J].Biochimica et Biophysica Acta:General Subjects,2016,1860(4):765-774.
[23] 杨建锋,戴宁.肠道黏膜免疫在肠易激综合征发病中的作用[J].中华消化杂志,2010,30(4):282-285.
[24] PICHE T,BARBARA G,AUBERT P,et al.Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome:involvement of soluble mediators[J].Gut,2009,58(2):196-201.
[25] COËFFIER M,GLORO R,BOUKHETTALA N,et al.Increased proteasome-mediated degradation of occludin in irritable bowel syndrome[J].The American Journal of Gastroenterology,2010,105(5):1181-1188.
[26] BASUROY S,SETH A,ELIAS B,et al.MAPK interacts with occludin and mediates EGF-induced prevention of tight junction disruption by hydrogen peroxide[J].Biochemical Journal,2006,393(1):69-77.
[27] 高欣,张振玉,吴海露,等.雷贝拉唑对NSAIDs相关小肠损伤大鼠紧密连接蛋白Occludin表达的影响及其机制[J].胃肠病学和肝病学杂志,2012,21(8):771-774.
[28] AL-SADI R M,MA T Y.IL-1β causes an increase in intestinal epithelial tight junction permeability[J].The Journal of Immunology,2007,178(7):4641-4649.
[29] SAPPINGTON P L,HAN X N,YANG R K,et al.Ethyl pyruvate ameliorates intestinal epithelial barrier dysfunction in endotoxemic mice and immunostimulated Caco-2 enterocytic monolayers[J].Journal of Pharmacology and Experimental Therapeutics,2003,304(1):464-476.
[30] LEDDER O,TURNER D.Antibiotics in IBD:still a role in the biological era?[J].Inflammatory Bowel Diseases,2018,24(8):1676-1688.
[31] SCHOENFELD P,PIMENTEL M,CHANG L,et al.Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation:a pooled analysis of randomised,double-blind,placebo-controlled trials[J].Alimentary Pharmacology and Therapeutics,2014,39(10):1161-1168.
[32] PIMENTEL M,CHOW E J,LIN H C.Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome:a double-blind,randomized,placebo-controlled study[J].The American Journal of Gastroenterology,2003,98(2):412-419.
[33] DOGAN B,SCHERL E,BOSWORTH B,et al.Multidrug resistance is common in
Escherichia coli associated with ileal Crohn's disease[J].Inflammatory Bowel Diseases,2013,19(1):141-150.
[34] BECKLER D R,ELWASILA S,GHOBRIAL G,et al.Correlation between
rpoB gene mutation in
Mycobacterium avium subspecies paratuberculosis and clinical rifabutin and rifampicin resistance for treatment of Crohn's disease[J].World Journal of Gastroenterology,2008,14(17):2723-2730.
[35] GOMOLLÓN F,DIGNASS A,ANNESE V,et al.3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016.Part 1:diagnosis and medical management[J].Journal of Crohn's and Colitis,2017,11(1):3-25.
[36] SZAJEWSKA H,CANANI RB,GUARINO A,et al.Probiotics for the prevention of antibiotic-associated diarrhea in children[J].Journal of Pediatric Gastroenterology Nutrition,2015,62(3):495-506.
[37] MAJEED M,NAGABHUSHANAM K,ARUMUGAM S,et al.
Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome:a randomised,double-blind,placebo controlled,multi-centre,pilot clinical study[J].Food & Nutrition Research.2018,62,doi:10.29219/fnr.v62.1218.
[38] SUN Y Y,LI M,LI Y Y,et al.The effect of
Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome:a randomized,double-blind,placebo-controlled trial[J].Scientific Reports,2018,8:2964.
[39] SRUTKOVA D,SCHWARZER M,HUDCOVIC T,et al.
Bifidobacterium longum CCM 7952 promotes epithelial barrier function and prevents acute DSS-induced colitis in strictly strain-specific manner[J].PLoS One,2015,10(7):e0134050.
[40] HOD K,DEKEL R,COHEN N A,et al.The effect of a multispecies probiotic on microbiota composition in a clinical trial of patients with diarrhea-predominant irritable bowel syndrome[J].Neurogastroenterology & Motility,2018,30(12):e13456.
[41] ISHAQUE S M,KHOSRUZZAMAN S M,AHMED D S,et al.A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult) in the management of diarrhea-predominant irritable bowel syndrome[J].BMC Gastroenterology,2018,18:71.
[42] PRESTON K,KRUMIAN R,HATTNER J,et al.
Lactobacillus acidophilus CL1285,
Lactobacillus casei LBC80R and
Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms:a double-blind,randomised,placebo-controlled study[J].Beneficial Microbes,2018,9(5):697-706.
[43] NG S C,PLAMONDON S,KAMM M A,et al.Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis[J].Inflammatory Bowel Diseases,2010,16(8):1286-1298.
[44] MANKERTZ J,TAVALALI S,SCHMITZ H,et al.Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma[J].Journal of Cell Science,2000,113(11):2085-2090.
[45] NWARIAKU F E,ROTHENBACH P,LIU Z J,et al.Rho inhibition decreases TNF-induced endothelial MAPK activation and monolayer permeability[J].Journal of Applied Physiology,2003,95(5):1889-1895.
[46] WANG X W,MAGOMED K,DING Z F,et al.Cross-talk between inflammation and angiotensin Ⅱ:studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA[J].Experimental Biology and Medicine,2012,237(12):1394-1401.
[47] 王建峰,程丽红,席红卫.p38MAPK对小儿急性肠梗阻肠坏死Occludin表达的影响及临床意义[J].中华小儿外科杂志,2017,38(2):95-98.
[48] JIN S,RAY R M,JOHNSON L R.TNF-α/cycloheximide-induced apoptosis in intestinal epithelial cells requires Rac1-regulated reactive oxygen species[J].American Journal of Physiology:Gastrointestinal and Liver Physiology,2008,294(4):G928-G937.
[49] WU Y P,ZHU C,CHEN Z,et al.Protective effects of
Lactobacillus plantarum on epithelial barrier disruption caused by enterotoxigenic
Escherichia coli in intestinal porcine epithelial cells[J].Veterinary Immunology and Immunopathology,2016,172:55-63.
[50] TU J,XU Y L,XU J Q,et al.Chitosan nanoparticles reduce LPS-induced inflammatory reaction via inhibition of NF-κB pathway in Caco-2 cells[J].International Journal of Biological Macromolecules,2016,86:848-856.
[51] CIANCIULLI A,CALVELLO R,CAVALLO P,et al.Modulation of NF-κB activation by resveratrol in LPS treated human intestinal cells results in downregulation of PGE2 production and
COX-2 expression[J].Toxicology
in Vitro,2012,26(7):1122-1128.
[52] WANG B,LI J J,CHEN J,et al.Effect of live
Lactobacillus plantarum L2 on TNF-α-induced MCP-1 production in Caco-2 cells[J].International Journal of Food Microbiology,2010,142(1/2):237-241.
[53] SHIMAZU T,VILLENA J,TOHNO M,et al.Immunobiotic
Lactobacillus jensenii elicits anti-inflammatory activity in porcine intestinal epithelial cells by modulating negative regulators of the Toll-like receptor signaling pathway[J].Infection and Immunity,2012,80(1):276-288.
[54] ZHANG L Y,LI N,CAICEDO R,et al.Alive and dead
Lactobacillus rhamnosus GG decrease tumor necrosis factor-α-induced interleukin-8 production in Caco-2 cells[J].The Journal of Nutrition,2005,135(7):1752-1756.
[55] GHADIMI D,DE VRESE M,HELLER K J,et al.Effect of natural commensal-origin DNA on Toll-like receptor 9(TLR9) signaling cascade,chemokine
IL-8 expression,and barrier integritiy of polarized intestinal epithelial cells[J].Inflammatory Bowel Diseases,2010,16(3):410-427.
[56] CHATURVEDI L S,MARSH H M,BASSON M D.Role of RhoA and its effectors ROCK and mDia1 in the modulation of deformation-induced FAK,ERK,p38,and MLC motogenic signals in human Caco-2 intestinal epithelial cells[J].American Journal of Physiology-Cell Physiology,2011,301(5):C1224-C1238.
[57] YE D M,MA I,MA T Y.Molecular mechanism of tumor necrosis factor-α modulation of intestinal epithelial tight junction barrier[J].American Journal of Physiology:Gastrointestinal and Liver Physiology,2006,290(3):G496-G504.
[58] GUO S S,GILLINGHAM T,GUO Y M,et al.Secretions of
Bifidobacterium infantis and
Lactobacillus acidophilus protect intestinal epithelial barrier function[J].Journal of Pediatric Gastroenterology and Nutrition,2017,64(3):404-412.
[59] AL-SADI R,GUO S H,YE D M,et al.Mechanism of IL-1β modulation of intestinal epithelial barrier involves p38 kinase and activating transcription factor-2 activation[J].The Journal of Immunology,2013,190(12):6596-6606.
[60] AL-SADI R,YE D M,DOKLADNY K,et al.Mechanism of IL-1β-induced increase in intestinal epithelial tight junction permeability[J].The Journal of Immunology,2008,180(8):5653-5661.
[61] AL-SADI R,YE D M,SAID H M,et al.Cellular and molecular mechanism of interleukin-1β modulation of Caco-2 intestinal epithelial tight junction barrier[J].Journal of Cellular and Molecular Medicine,2011,15(4):970-982.
[62] 霍丽娟,赵和平.益生菌对溃疡性结肠炎大鼠结肠黏膜中
IL-1和
TNF-α表达的影响[J].山西医科大学学报,2004,35(4):341-343,349.
[63] WATSON C J,HOARE C J,GARROD D R,et al.Interferon-γ selectively increases epithelial permeability to large molecules by activating different populations of paracellular pores[J].Journal of Cell Science,2005,118(22):5221-5230.
[64] BOIVIN M A,ROY P K,BRADLEY A,et al.Mechanism of interferon-γ-induced increase in T84 intestinal epithelial tight junction[J].Journal of Interferon & Cytokine Research,2009,29(1):45-54.
[65] 叶胜青,丁在咸,张旻,等.植物乳杆菌对白细胞介素-10基因敲除小鼠结肠炎的治疗作用[J].中华消化杂志,2011,31(9):619-624.
[66] 刘伟,戎兰,丁伟群,等.益生菌对结肠炎大鼠黏膜和系统水平细胞因子的影响[J].复旦学报(医学版),2008,35(2):278-281.
[67] LIU L,ZENG D,YANG M Y,et al.Probiotic
Clostridium butyricum improves the growth performance,immune function,and gut microbiota of weaning Rex rabbits[J].Probiotics and Antimicrobial Proteins,2019,11(4):1278-1292.
[68] ZHOU Y,NI X Q,WEN B,et al.Appropriate dose of
Lactobacillus buchneri supplement improves intestinal microbiota and prevents diarrhoea in weaning Rex rabbits[J].Beneficial Microbes,2018,9(3):401-416.
[69] SUN H,NI X Q,SONG X,et al.Fermented
Yupingfeng polysaccharides enhance immunity by improving the foregut microflora and intestinal barrier in weaning Rex rabbits[J].Applied Microbiology and Biotechnology,2016,100(18):8105-8120.
[70] YU Q,WANG Z,YANG Q.
Lactobacillus amylophilus D14 protects tight junction from enteropathogenic bacteria damage in Caco-2 cells[J].Journal of Dairy Science,2012,95(10):5580-5587.
[71] WU H L,GAO X,JIANG Z D,et al.Attenuated expression of the tight junction proteins is involved in clopidogrel-induced gastric injury through p38 MAPK activation[J].Toxicology,2013,304:41-48.
[72] LIU Z H,TIAN Y H,JIANG Y Q,et al.Protective effects of Let-7b on the expression of occludin by targeting p38 MAPK in preventing intestinal barrier dysfunction[J].Cellular Physiology and Biochemistry,2018,45(1):343-355.
[73] 刘志华.乳酸杆菌表面蛋白活性片段MIMP诱导肠上皮细胞MAPK信号通路调控occludin表达的机制研究[D].博士学位论文.上海:上海交通大学,2011.
[74] SEGAWA S,FUJIYA M,KONISHI H,et al.Probiotic-derived polyphosphate enhances the epithelial barrier function and maintains intestinal homeostasis through integrin-p38 MAPK pathway[J].PLoS One,2011,6(8):e23278.
[75] LIU Z H,SHEN T Y,ZHANG P,et al.
Lactobacillus plantarum surface layer adhesive protein protects intestinal epithelial cells against tight junction injury induced by enteropathogenic
Escherichia coli[J].Molecular Biology Reports,2011,38(5):3471-3480.
[76] PAPARO L,AITORO R,NOCERINO R,et al.Direct effects of fermented cow's milk product with
Lactobacillus paracasei CBA L74 on human enterocytes[J].Beneficial Microbes,2018,9(1):165-172.
京公网安备 11010802041926号